BML Investment Partners, L.P. 13D and 13G filings for Pardes Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-08 5:09 pm Unchanged | 2023-02-08 | 13G | Pardes Biosciences, Inc. PRDS | BML Investment Partners, L.P. | 4,867,984 7.800% | 0 (Unchanged) | Filing |
| 2022-12-30 5:30 pm Purchase | 2022-12-21 | 13G | Pardes Biosciences, Inc. PRDS | BML Investment Partners, L.P. | 4,867,984 7.800% | 4,867,984 (New Position) | Filing |